- Latest available (Revised)
- Original (As adopted by EU)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
This version of this Decision was derived from EUR-Lex on IP completion day (31 December 2020 11:00 p.m.). It has not been amended by the UK since then. Find out more about legislation originating from the EU as published on legislation.gov.uk.![]()
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
1.The survey programmes for avian influenza in poultry and wild birds submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden and the United Kingdom are hereby approved for the period from 1 January to 31 December 2013.
The survey programme for avian influenza submitted by Croatia is hereby approved for the period from 1 July to 31 December 2013.
2.The financial contribution by the Union:
(a)shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:
[F1EUR 0,5 per domestic bird sampled;]
EUR 5 per wild bird sampled in the framework of the passive surveillance;
EUR 1 per ELISA test;
EUR 1 per agar gel immune diffusion test;
(b)shall be at the rate of 50 % of the costs to be incurred by each Member State for the costs of carrying out laboratory tests other than those foreseen in point (a); and
[F1(c) shall not exceed the following:
EUR 24 000 for Belgium;
EUR 9 000 for Bulgaria;
EUR 14 000 for the Czech Republic;
EUR 53 000 for Denmark;
EUR 135 000 for Germany;
EUR 62 000 for Ireland;
EUR 8 000 for Greece;
EUR 67 000 for Spain;
EUR 108 000 for France;
EUR 40 000 for Croatia;
EUR 1 300 000 for Italy;
EUR 4 000 for Cyprus;
EUR 13 000 for Latvia;
EUR 5 000 for Lithuania;
EUR 6 000 for Luxembourg;
EUR 61 000 for Hungary;
EUR 8 000 for Malta;
EUR 154 000 for the Netherlands;
EUR 30 000 for Austria;
EUR 70 000 for Poland;
EUR 14 000 for Portugal;
EUR 350 000 for Romania;
EUR 29 000 for Slovenia;
EUR 16 000 for Slovakia;
EUR 25 000 for Finland;
EUR 30 000 for Sweden;
EUR 100 000 for the United Kingdom.]
3.The maximum of the costs to be reimbursed to the Member States for the tests covered by the programmes shall on average not exceed:
:
EUR 12 per test;
:
EUR 40 per test;
:
EUR 20 per test.
Textual Amendments
F1 Substituted by Commission Implementing Decision of 13 December 2013 approving certain amended programmes for the eradication, control and monitoring of animal diseases and zoonoses for the year 2013, amending Decision 2008/897/EC approving annual and multiannual programmes for 2009 and following years and amending Implementing Decision 2012/761/EU as regards the Union financial contribution for certain programmes approved by that Decision (notified under document C(2013) 8891) (2013/766/EU).
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: